Tagged with Investment,

Taiwan Rongjin Lin, chairman of Center Ventures and Center Laboratories shares his story of how he revived Center Laboratories from the brink of bankruptcy and repositioned the pharmaceutical company to become one of Taiwan’s leading biotechnology capital funds. Lin goes on to share his view on the Taiwanese biotech investment landscape,…

Puerto Rico Ivan Lugo, executive director at Puerto Rico’s Industry University Research Center, Inc. (INDUNIV) with over 40 years of global pharmaceutical expertise, explains how his not-for-profit organization promotes Puerto Rico’s competitiveness in science and technology by facilitating collaboration between industry, government and academia. He also highlights how the island aims to…

Puerto Rico With more than 50 years of experience in pharmaceutical manufacturing, Puerto Rico is today a manufacturing base for 11 of the world’s 20 largest pharmaceutical and biopharmaceutical companies. However, considering its economic struggles and rising competition both from US states and international manufacturing hubs such as Ireland and Singapore, the…

China The company sold 551 million shares in the latest IPO on the Hong Kong Exchange and plans to invest half of its earnings in R&D. Hong Kong is now the second largest biotech funding hub in the world.    Hansoh Pharmaceutical, one of China’s fastest-growing pharma companies, raised a billion…

Spain Jesús Donado, CEO of B. Braun Spain introduces the company’s strong footprint in Spain, as a manufacturing hub and a global centre of excellence for the company. Donado also discusses the challenge of offering solution and treatment-based services, while having to sell through product and volume-based tenders.   We are…

Sweden Swecare Foundation is a platform where academia, public sector actors, and the private sector come together to promote the internationalization and export growth of Swedish healthcare and life sciences. Anna Riby, regional director East Asia, Shampa Bari, regional director South Asia and Cécilia Wismar, office manager/CEO assistant, explain how the…

Opinion David H. Crean highlights R&D efforts and ongoing investments in Alzheimer’s disease treatments as we enter the month of June, brain awareness month.   Alzheimer’s disease is a complex chronic disease characterized biologically by the accumulation of extracellular protein plaques, neurofibrillary protein tangles, a loss of functional synaptic connections, and eventually…

China On May 30th, and with much fanfare, Pfizer Upjohn officially inaugurated its global headquarters in the heart of Shanghai, China. Following a global re-organization mid-2018, Pfizer now operates three business units, namely Innovative Medicines (including biosimilars and a new hospital business unit dealing with anti-infectives and sterile injectables), Consumer Healthcare,…

AI Axel Schumacher highlights the vital importance of AI and blockchain for the future success of pharmaceutical companies, the significant knowledge gap that currently exists within Big Pharma, and why, therefore, now is the time for these firms to invest in AI and blockchain start-ups.   While almost everyone is talking…

Egypt Dr Maged George, chairman of the Egyptian Export Council of Medical Industries, highlights the obstacles that the Egyptian pharmaceutical industry is facing in the wake of the currency devaluation both locally and abroad. He also gives insights into Egypt’s new consolidated approach of targeting other African countries for exports, uniting…

Egypt Janet Heckman, managing director for the southern and eastern Mediterranean region at the European Bank for Reconstruction and Development (EBRD), discusses the main areas of investment for the Bank and the crucial role Egypt plays in the region. She shares her views on the attractiveness of the country for foreign…

Egypt Marwa Taher, executive director of the Swiss Egyptian Business Association (SEBA), explains how the association is promoting trade relations between the two countries. She also highlights initiatives of both SEBA and Swiss companies to improve healthcare and the wellbeing of Egyptian citizens.   There is strong initiative from both countries…